Cargando…

First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine

Detalles Bibliográficos
Autores principales: Havla, Joachim, Schultz, Yannick, Zimmermann, Hanna, Hohlfeld, Reinhard, Danek, Adrian, Kümpfel, Tania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193159/
https://www.ncbi.nlm.nih.gov/pubmed/34115170
http://dx.doi.org/10.1007/s00415-021-10648-w
_version_ 1783706197070708736
author Havla, Joachim
Schultz, Yannick
Zimmermann, Hanna
Hohlfeld, Reinhard
Danek, Adrian
Kümpfel, Tania
author_facet Havla, Joachim
Schultz, Yannick
Zimmermann, Hanna
Hohlfeld, Reinhard
Danek, Adrian
Kümpfel, Tania
author_sort Havla, Joachim
collection PubMed
description
format Online
Article
Text
id pubmed-8193159
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-81931592021-06-11 First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine Havla, Joachim Schultz, Yannick Zimmermann, Hanna Hohlfeld, Reinhard Danek, Adrian Kümpfel, Tania J Neurol Letter to the Editors Springer Berlin Heidelberg 2021-06-11 2022 /pmc/articles/PMC8193159/ /pubmed/34115170 http://dx.doi.org/10.1007/s00415-021-10648-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editors
Havla, Joachim
Schultz, Yannick
Zimmermann, Hanna
Hohlfeld, Reinhard
Danek, Adrian
Kümpfel, Tania
First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
title First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
title_full First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
title_fullStr First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
title_full_unstemmed First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
title_short First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
title_sort first manifestation of multiple sclerosis after immunization with the pfizer-biontech covid-19 vaccine
topic Letter to the Editors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193159/
https://www.ncbi.nlm.nih.gov/pubmed/34115170
http://dx.doi.org/10.1007/s00415-021-10648-w
work_keys_str_mv AT havlajoachim firstmanifestationofmultiplesclerosisafterimmunizationwiththepfizerbiontechcovid19vaccine
AT schultzyannick firstmanifestationofmultiplesclerosisafterimmunizationwiththepfizerbiontechcovid19vaccine
AT zimmermannhanna firstmanifestationofmultiplesclerosisafterimmunizationwiththepfizerbiontechcovid19vaccine
AT hohlfeldreinhard firstmanifestationofmultiplesclerosisafterimmunizationwiththepfizerbiontechcovid19vaccine
AT danekadrian firstmanifestationofmultiplesclerosisafterimmunizationwiththepfizerbiontechcovid19vaccine
AT kumpfeltania firstmanifestationofmultiplesclerosisafterimmunizationwiththepfizerbiontechcovid19vaccine